Sánchez-Ortega I - Search Results

1

A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection.

Parody R, Sánchez-Ortega I, Mussetti A, Patiño B, Arnan M, Pomares H, González-Barca E, Mercadal S, Boqué C, Maluquer C, Carro I, Peña M, Clapés V, Verdesoto S, Bustamante G, Oliveira AC, Baca C, Cabezudo E, Talarn C, Escoda L, Ortega S, García N, Isabel González-Medina M, Sánchez-Salmerón M, Fusté C, Villa J, Carreras E, Domingo-Domènech E, Sureda A. Parody R, et al. Bone Marrow Transplant. 2022 Feb;57(2):176-182. doi: 10.1038/s41409-021-01506-4. Epub 2021 Oct 28. Bone Marrow Transplant. 2022. PMID: 34711917

2

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.

Sánchez-Ortega I, Patiño B, Arnan M, Peralta T, Parody R, Gudiol C, Encuentra M, Fernández de Sevilla A, Duarte RF. Sánchez-Ortega I, et al. Bone Marrow Transplant. 2011 May;46(5):733-9. doi: 10.1038/bmt.2010.185. Epub 2010 Aug 9. Bone Marrow Transplant. 2011. PMID: 20697369

3

Thyroid dysfunction in adult patients late after autologous and allogeneic blood and marrow transplantation.

Sánchez-Ortega I, Canals C, Peralta T, Parody R, Clapés V, de Sevilla AF, Duarte RF. Sánchez-Ortega I, et al. Bone Marrow Transplant. 2012 Feb;47(2):296-8. doi: 10.1038/bmt.2011.54. Epub 2011 Mar 21. Bone Marrow Transplant. 2012. PMID: 21423119 No abstract available.

4

Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host disease.

Sánchez-Ortega I, Servitje O, Arnan M, Ortí G, Peralta T, Manresa F, Duarte RF. Sánchez-Ortega I, et al. Biol Blood Marrow Transplant. 2012 Feb;18(2):318-23. doi: 10.1016/j.bbmt.2011.10.042. Epub 2011 Nov 7. Biol Blood Marrow Transplant. 2012. PMID: 22068151 Free article. Clinical Trial.

5

Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients.

Sánchez-Ortega I, Vázquez L, Montes C, Patiño B, Arnan M, Bermúdez A, Yáñez L, Caballero T, Duarte RF. Sánchez-Ortega I, et al. Antimicrob Agents Chemother. 2012 Dec;56(12):6422-4. doi: 10.1128/AAC.01489-12. Epub 2012 Oct 1. Antimicrob Agents Chemother. 2012. PMID: 23027192 Free PMC article.

6

Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation.

Sánchez-Ortega I, Patiño B, Muñoz C, Arnan M, Peralta T, Clopés A, de Sevilla AF, Duarte RF. Sánchez-Ortega I, et al. J Med Econ. 2013;16(6):736-43. doi: 10.3111/13696998.2013.791301. Epub 2013 Apr 12. J Med Econ. 2013. PMID: 23541251 Free article.

7

Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia.

Sánchez-Ortega I, Arnan M, Patiño B, Herrero MJ, Querol S, Duarte RF. Sánchez-Ortega I, et al. Bone Marrow Transplant. 2014 Jan;49(1):145-7. doi: 10.1038/bmt.2013.113. Epub 2013 Aug 12. Bone Marrow Transplant. 2014. PMID: 23933757 No abstract available.

8

Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.

Gudiol C, Garcia-Vidal C, Arnan M, Sánchez-Ortega I, Patiño B, Duarte R, Carratalà J. Gudiol C, et al. Bone Marrow Transplant. 2014 Jun;49(6):824-30. doi: 10.1038/bmt.2014.37. Epub 2014 Mar 24. Bone Marrow Transplant. 2014. PMID: 24662420

9

Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.

Duarte RF, Sánchez-Ortega I, Cuesta I, Arnan M, Patiño B, Fernández de Sevilla A, Gudiol C, Ayats J, Cuenca-Estrella M. Duarte RF, et al. Clin Infect Dis. 2014 Dec 15;59(12):1696-702. doi: 10.1093/cid/ciu673. Epub 2014 Aug 27. Clin Infect Dis. 2014. PMID: 25165088

10

Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization.

Sánchez-Ortega I, Querol S, Encuentra M, Ortega S, Serra A, Sanchez-Villegas JM, Grifols JR, Pujol-Balaguer MM, Pujol-Bosch M, Martí JM, Garcia-Cerecedo T, Barba P, Sancho JM, Esquirol A, Sierra J, Duarte RF. Sánchez-Ortega I, et al. Bone Marrow Transplant. 2015 Jan;50(1):34-9. doi: 10.1038/bmt.2014.196. Epub 2014 Sep 15. Bone Marrow Transplant. 2015. PMID: 25222503 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters